Who Owns PVLA?

Palvella Therapeutics, Inc. — Institutional Ownership & 13F Holdings

$128.11

-0.53 (-0.41%)

Market Cap

$1.5B

Shares Outstanding

11,837,430

Institutional Holders

41

Total Inst. Value

$135.9M

% of Float Held

63.8%

QoQ Holder Change

Institutional data as of Q1 2025

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1SUVRETTA CAPITAL MANAGEMENT, LLC$20.0M714,463
2BVF INC/IL$19.5M696,555
3Frazier Life Sciences Management, L.P.$19.3M690,012
4Samsara BioCapital, LLC$19.0M679,486
5ADAMS STREET PARTNERS LLC$11.5M409,666
6Nantahala Capital Management, LLC$7.0M250,062
7Woodline Partners LP$5.4M194,167
8Opaleye Management Inc.$4.8M172,357
9Blue Owl Capital Holdings LP$3.9M140,259
10VANGUARD GROUP INC$3.9M138,433

Biggest Buyers & Sellers This Quarter

Famous Fund Managers

Related Stocks

Frequently Asked Questions

How many institutional investors hold PVLA?

As of Q1 2025, 41 institutional investors report holding PVLA (Palvella Therapeutics, Inc.) in their 13F filings.

What percentage of Palvella Therapeutics, Inc. is owned by institutions?

Institutional investors hold approximately 63.8% of Palvella Therapeutics, Inc.'s float as reported in SEC 13F filings.

Which hedge fund owns the most PVLA?

The largest institutional holder of PVLA is SUVRETTA CAPITAL MANAGEMENT, LLC with $20.0M in shares.

Are institutions buying or selling PVLA?

This quarter, 15 institutions opened new positions in PVLA and 8 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.